BARBUI: 'Phase IIa study of ITF2357, Study No. 07/2357/28' (B1)

WO-A1-2004/064824 (B1)

GUERINI V ET AL: "The histone deacetylase inhibitor ITF2357 selectively targets cells bearing mutated JAK2(V617F)" LEUKEMIA (BASINGSTOKE), vol. 22, no. 4, April 2008 (2008-04), pages 740-747, XP008114983 ISSN: 0887-6924 (B1)

GUERINI VITTORIA ET AL: "Potent inhibition of EEC colony formation in JAK2(V617F) PV and ET by low doses of ITF2357, a new histone deacetylase inhibitor." BLOOD, vol. 108, no. 11, Part 1, November 2006 (2006-11), page 764A, XP008114978 & 48TH ANNUAL MEETING OF THE AMERICAN-SOCIETY-OF-HEMATOLOGY; ORLANDO, FL, USA; DECEMBER 09 -12, 2006 ISSN: 0006-4971 (B1)

GUERINI VITTORIA ET AL: "Selective targeting of the JAK2(V617F) mutation in polycythemia vera and essential thrombocythemia by ITF2357, a novel histone deacetylase inhibitor" BLOOD, vol. 110, no. 11, Part 1, November 2007 (2007-11), pages 170A-171A, XP008114980 & 49TH ANNUAL MEETING OF THE AMERICAN-SOCIETY-OF-HEMATOLOGY; ATLANTA, GA, USA; DECEMBER 08 -11, 2007 ISSN: 0006-4971 (B1)

MARTIN P ET AL: "HEL cells: a new human erythroleukemia cell line with spontaneous and induced globin expression", SCIENCE, AMERICAN ASSOCIATION FOR THE ADVANCEMENT OF SCIENCE, WASHINGTON, DC; US, vol. 216, no. 4551, 11 June 1982 (1982-06-11), pages 1233-1235, XP008160201, ISSN: 0036-8075, DOI: 10.1126/SCIENCE.6177045 (B1)

OLDONI: 'Clinical development, ITF2357,Study No. 03/2357/09' (B1)

RAMBALDI: 'Phase II study of ITF2357, Study No. 08/2357/38' (B1)

RUZICKA: 'Integrated repot, ITF2357,Study No. 03/2357/07' (B1)

UOZUMI: "Establishment and characterization of a new...", LEUKEMIA, vol. 14, 2000, pages 142-152, (B1)

US-A1- 2009 088 410 (B1)

VOJINOVIC JELENA ET AL: "Safety and efficacy of oral ITF 2357 in patients with active systemic onset juvenile idiopathic arthritis (SOJIA) - Results of a phase II, open label, international, Multicentre clinical trial", ARTHRITIS & RHEUMATISM, vol. 58, no. 9, Suppl. S, September 2008 (2008-09), page S943, & 72ND ANNUAL SCIENTIFIC MEETING OF THE AMERICAN-COLLEGE-OF-RHEUMATOLOGY/43RD ANNUAL SCIENTIFIC MEETIN; SAN FRANCISCO, CA, USA; OCTOBER 24 -29, 2008 ISSN: 0004-3591 (B1)

WO-A-2006/063294 (B1)

WO-A-2007/016354 (B1)

WO-A-2008/058287 (B1)

WO-A-2008/082646 (B1)

BONFANTE V ET AL: "PHASE II STUDY OF THE HISTONE-DEACIETYLASE INHIBITOR ITF2357 IN RELAPSED/REFRACTORY HODGKIN'S LYMPHOMA PATIENTS", HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, vol. 93, no. Suppl. 1, June 2008 (2008-06) , page 244, & 13TH CONGRESS OF THE EUROPEAN-HEMATOLOGY-ASSOCIATION; COPENHAGEN, DENMARK; JUNE 12 -15, 2008 ISSN: 0390-6078(print) (B1)